Gregory Bailey, Director at Serina Therapeutics, Inc. (SER), bought 6,378 shares at $9.50 ($61K) on 2024-05-30, disclosed to the SEC on 2024-05-31.
Open-market purchase of $61k SER by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.50 | 1,173 | $11K | 18.4% |
| 2 | $9.50 | 5,205 | $49K | 81.6% |
| Total | $9.50 avg | 6,378 | $61K | 100% |
| Filing → |
| BHVN | BUY | 2024-09-25 | $221K | — | Filing → |
| SER | BUY | 2024-09-24 | $7K | — | Filing → |
| SER | BUY | 2024-09-20 | $88K | — | Filing → |